Novel Casein Kinase II (CK2) inhibitor BMS-135 shows significant in vivo anti-leukemia effect

Research output: Contribution to journal › Article › peer-review

All Science Journal Classification (ASJC) codes

@article{4ebe280b85544c71a8ed1faf0cf89ac6,

title = "Novel Casein Kinase II (CK2) inhibitor BMS-135 shows significant in vivo anti-leukemia effect",

author = "C. Gowda and A. Purandare and K. Mercer and K. Duke and S. Dovat",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00879-6",

language = "English (US)",

volume = "174",

pages = "S29",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

TY - JOUR

T1 - Novel Casein Kinase II (CK2) inhibitor BMS-135 shows significant in vivo anti-leukemia effect

AU - Gowda, C.

AU - Purandare, A.

AU - Mercer, K.

AU - Duke, K.

AU - Dovat, S.

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85140477473

UR - https://www.scopus.com/pages/publications/85140477473#tab=citedBy

U2 - 10.1016/S0959-8049(22)00879-6

DO - 10.1016/S0959-8049(22)00879-6

M3 - Article

AN - SCOPUS:85140477473

SN - 0959-8049

VL - 174

SP - S29

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -